Transcriptional activation of follistatin by Nrf2 protects pulmonary epithelial cells against silica nanoparticle-induced oxidative stress

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Lin, Chen ^a   Zhao, Xinyuan ^a   Sun, Desen ^a   Zhang, Lingda ^a   Fang, Wenpan ^a   Zhu, Tingjia ^a   Wang, Qiang ^a   Liu, Botao ^a   Wei, Saisai ^c   Chen, Guangdi ^a   Xu, Zhengping ^a,b   Gao, Xiangwei ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLISTATIN; MEMBRANE PROTEIN; NANOPARTICLE; NOX1 PROTEIN, HUMAN; NOX5 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SILICON DIOXIDE; TRANSCRIPTION FACTOR NRF2;

ANIMAL; APOPTOSIS; CELL LINE; GENE EXPRESSION; GENETICS; HUMAN; LUNG ALVEOLUS EPITHELIUM CELL; MALE; METABOLISM; MOUSE; OXIDATIVE STRESS; TRANSCRIPTION INITIATION;

ALVEOLAR EPITHELIAL CELLS; ANIMALS; APOPTOSIS; CELL LINE; FOLLISTATIN; GENE EXPRESSION; HUMANS; MALE; MEMBRANE PROTEINS; MICE; NADPH OXIDASE; NANOPARTICLES; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SILICON DIOXIDE; TRANSCRIPTIONAL ACTIVATION;

EID: 84958259481     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21133     Document Type: Article

References (26)

1. Nel, A., Xia, T., Madler, L., Li, N. Toxic potential of materials at the nanolevel. Science 311, 622-627 (2006).
2. Nel, A. E. et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8, 543-557 (2009).
3. Oberdorster, G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 267, 89-105 (2010).
4. Li, Z., Barnes, J. C., Bosoy, A., Stoddart, J. F., Zink, J. I. Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev 41, 2590-2605 (2012).
5. Brown, D. M., Kanase, N., Gaiser, B., Johnston, H., Stone, V. Inflammation and gene expression in the rat lung after instillation of silica nanoparticles: effect of size, dispersion medium and particle surface charge. Toxicol Lett 224, 147-156 (2014).
6. Ma, Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 53, 401-426 (2013).
7. Li, N. et al. Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals. J Immunol 173, 3467-3481 (2004).
8. Kang, S. J., Ryoo, I. G., Lee, Y. J., Kwak, M. K. Role of the Nrf2-heme oxygenase-1 pathway in silver nanoparticle-mediated cytotoxicity. Toxicol Appl Pharmacol 258, 89-98 (2012).
9. Hemmati-Brivanlou, A., Kelly, O. G., Melton, D. A. Follistatin, an antagonist of activin, is expressed in the Spemann organizer and displays direct neuralizing activity. Cell 77, 283-295 (1994).
10. Nakamura, T. et al. Activin-binding protein from rat ovary is follistatin. Science 247, 836-838 (1990).
11. Amthor, H. et al. Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev Biol 270, 19-30 (2004).
12. Glister, C., Kemp, C. F., Knight, P. G. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4,-6 and-7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction 127, 239-254 (2004).
13. Gao, X. et al. Nucleolar follistatin promotes cancer cell survival under glucose-deprived conditions through inhibiting cellular rRNA synthesis. J Biol Chem 285, 36857-36864 (2010).
14. Gao, X. et al. Reduction of AUF1-mediated follistatin mRNA decay during glucose starvation protects cells from apoptosis. Nucleic Acids Res 42, 10720-10730 (2014).
15. Lim, R. et al. Activin and NADPH-oxidase in preeclampsia: insights from in vitro and murine studies. Am J Obstet Gynecol 212, 86 e81-12 (2015).
16. Jiang, M. et al. BMP-driven NRF2 activation in esophageal basal cell differentiation and eosinophilic esophagitis. J Clin Invest 125, 1557-1568 (2015).
17. Jenuwein, T., Allis, C. D. Translating the histone code. Science 293, 1074-1080 (2001).
18. Kaewamatawong, T. et al. Acute and subacute pulmonary toxicity of low dose of ultrafine colloidal silica particles in mice after intratracheal instillation. Toxicol Pathol 34, 958-965 (2006).
19. Lin, W., Huang, Y. W., Zhou, X. D., Ma, Y. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol 217, 252-259 (2006).
20. Kaewamatawong, T. et al. Acute pulmonary toxicity caused by exposure to colloidal silica: particle size dependent pathological changes in mice. Toxicol Pathol 33, 743-749 (2005).
21. Lambeth, J. D. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4, 181-189 (2004).
22. Brand, M. D. The sites and topology of mitochondrial superoxide production. Exp Gerontol 45, 466-472 (2010).
23. Sriram, S. et al. Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-kappaB. Aging Cell 10, 931-948 (2011).
24. Panas, A. et al. Screening of different metal oxide nanoparticles reveals selective toxicity and inflammatory potential of silica nanoparticles in lung epithelial cells and macrophages. Nanotoxicology 7, 259-273 (2013).
25. Shi, J. et al. Microsomal glutathione transferase 1 protects against toxicity induced by silica nanoparticles but not by zinc oxide nanoparticles. ACS Nano 6, 1925-1938 (2012).
26. Livak, K. J., Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408 (2001).